Newsletter

Hi and good morning,

This morning we’re looking at a company that was founded in 1960 with impressive fundamentals and a potentially explosive chart. It’s a combination we don’t see very often, so let’s get right to it:

Today’s profile is:

Lescarden, Inc. (LCAR)

Website: www.catrix.com

Quote: LCAR Quote

We’re looking at LCAR today primarily due to fundamentals, recent activity and its chart with several indicators currently flashing Green:

  - Just 63Mln shares outstanding (OTCMarkets)

  - A small float of less than 16Mln (Yahoo)

  - A hefty 74pct held by insiders (Yahoo)

  - Incepted over 50 Years ago

Trending around .01, the chart has the potential to be a giant given the small float and insider positions.

LCAR just hit its 52-week low two days ago; we could be looking at a potentially big bottom bouncer.

  - The 52-week high is .09

  - The 52-week low is .0099

LCAR has been trading in the .01 to .02 range since October of last year. In that time, however, there have been several spikes of large percentages.

Considering these spikes, the amount of time it’s spent forming a base, the small float and the large amount of space between its current level and the year’s high…

… we could be looking at a play with serious bottom bouncer potential!

Let’s move on:

Operations: Since its inception in 1960, Lescarden has devoted its resources to fund research and development of proprietary biologic materials with a focus on wound healing, clinical skin care, osteoarthritis and cancer applications.

In the ensuing years, significant studies substantiated the ability of Catrix, Lescarden's proprietary cartilage powder, to function as a biological response modifier by stimulating the body's immune system. This response has significant, demonstrated benefits for chronic wound management, and has been investigated as a potential treatment for certain types of cancer.

Further studies indicated that Catrix has potent anti-inflammatory properties that could also be effective against diseases such as arthritis, scleroderma and psoriasis.

With a solid clinical platform, the Company in recent years has focused its strategy toward pursuing marketing and licensing opportunities for fully developed products that have received patents and are ready for commercialization.

It is important to also note that the Company’s most recent filing (filed January 13, 2016 for the period ending November 30, 2015) states:

“The results of operations for the three and six month periods ended November 30, 2014 reflect decreased sales and operating losses due to an ongoing production outage. Preliminary testing of product samples from an alternative supplier suggests that the Company will be able to resume production operations within the next six months.

Regulatory certification of the new suppler is required prior to product shipment which could further delay the fulfillment of existing purchase orders after the resumption of production operations.

Revenues for the six-months ended November 30, 2015 consisted solely of sales of skin-care and nutritional supplements”

So what does all of this mean?

Well, we could be looking at a rare situation. The Company’s numbers have dropped of late, which could be the leading cause for the drop in price to its current level of just .0099…

… but with LCAR stating that it expects “the Company will be able to resume production operations” in its most recent filing, we could see those numbers rise again in the near future.

So look out, this potential bottom bouncer could have the fundamentals to substantiate something special!

LCAR has maintained its quarterly and annual filings and is currently listed as “OTC Pink Current Information” on OTCMarkets.

As stated at the start, we are focused on LCAR today primarily due to fundamentals, recent activity and its chart that currently has several green indicators… let’s check out a few of those short-term indicators:

Exponential Moving Average (EMA) Analysis: Bullish

Moving Average Convergence Divergence (MACD) Analysis: Very Bullish

Fibonacci Analysis: Bullish

Low Analysis: Very Bullish

Stochastic Analysis: Very Bullish

If LCAR were to catch fire it could be a huge bottom bouncer that may have a LOT of running room.

Currently at just .0099 there could be a large upside.

Get started on your research right away. It is important that you realize the highly speculative nature of this situation.

Remember, we always encourage you to do further research. Never take our word for it, read our disclaimer to see why, and of course always consult a professional.

Just because a situation looks great things can still go wrong and often do. Be smart and protect yourself.

Enjoy your morning,

Exp